ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands.

Daniel Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.